|
Public Offerings and Listings 公开招股及上市项目 |
HONG KONG STOCK EXCHANGE MiniMax Group Inc.– HK IPO - closed on 9 January 2026 MiniMax Group Inc.–于香港的首次公开招股项目 – 于2026年1月9日完成 Press release: Maples Group Advises MiniMax on Successful Hong Kong IPO - Maples Group Maples advised MiniMax Group Inc. ("MiniMax") in relation to its initial public offering ("IPO") on the Main Board of the Hong Kong Stock Exchange. The offering, which closed on 9 January 2026, raised gross proceeds of approximately HK$4.8 billion. MiniMax intends to use the proceeds to fund the research and development of its foundation models and AI‑native products over the next five years. MiniMax is a leading Chinese artificial intelligence (AI) company based in Shanghai, backed by Alibaba Group Holding and Abu Dhabi's sovereign wealth fund. The company specialises in AI applications, including conversational agents, image generation and video synthesis. A team of lawyers based in the firm's Hong Kong office acted as Cayman Islands counsel to MiniMax and was led by Corporate Partner, Karen Zhang Pallaras and assisted by Corporate Legal Manager, Clare Tsang. The Maples Group's Fund Services team acted as the Cayman Islands Share Registrar, with a team comprising Eastern Fong, Regional Head of Fund Services – Asia and Senior Vice President, Christy Poon. Davis Polk & Wardwell acted as Hong Kong and US legal counsel to MiniMax. Jingtian & Gongcheng acted as the PRC legal counsel to MiniMax. Freshfields acted as Hong Kong and US legal counsel, and Commerce & Finance Law Offices acted as the PRC legal counsel to the joint sponsors and the underwriters. 迈普思欣然为MiniMax Group Inc.（简称"MiniMax"）于香港交易所主板的首次公开募股项目（简称"IPO"）提供法律咨询服务。该项目已于2026 年1 月9 日完成，募集资金总额约48 亿港元。 MiniMax 计划将所得款项用于未来五年大模型及人工智能原生产品的研发。MiniMax 是一家总部位于上海的中国领先人工智能公司，获Alibaba Group Holding 阿里巴巴集团控股及阿布扎比主权财富基金的支持。MiniMax 专注于人工智能应用领域，涵盖对话助手、图像生成及视频合成。 迈普达律师事务所香港分所的律师团队担任MiniMax 的开曼群岛法律顾问。该团队由企业事务合伙人Karen Zhang Pallaras 张那带领，并由法务经理Clare Tsang 曾卓颖协助。迈普思集团的基金服务团队担任开曼群岛股份登记处，其团队成员包括基金服务亚洲区域总监Eastern Fong 方东及高级副总裁Christy Poon 潘淑雯。 Davis Polk & Wardwell 担任MiniMax 的香港及美国法律顾问。竞天公诚律师事务所担任MiniMax 的中国内地法律顾问。富而德律师事务所担任MiniMax 的香港及美国法律顾问。北京市通商律师事务所担任联席保荐人及承销商的中国内地法律顾问。 Genor Biopharma Holdings Limited – HK IPO – closed on 30 December 2025 嘉和生物药业（开曼）控股有限公司 –于香港的首次公开招股项目 – 于2025年12月30日完成 Press release: Maples Group Advises on Landmark Reverse Takeover under Hong Kong Chapter 18A - Maples Group Maples advised Genor Biopharma Holdings Limited ("Genor Biopharma"), a company listed on the Hong Kong Stock Exchange ("HKEX") under Chapter 18A of the Listing Rules, on its merger with Edding Group Company Limited ("Edding Group"). Upon completion of the transaction on 30 December 2025, Genor Biopharma has been renamed to Edding Genor Group Holdings Limited and continues to be listed on the HKEX. The transaction implies a value of approximately US$874 million and marks the first reverse takeover involving a Chapter 18A listed company in Hong Kong's capital markets. The HKEX's Chapter 18A regime, introduced in 2018, was designed to attract pre-revenue issuers in high-growth technology and biotechnology sectors amid growing competition from the US and China mainland stock exchanges. Genor Biopharma is a China-based, innovation-driven biopharmaceutical company specialising in the discovery, development, and commercialisation of oncology and autoimmune therapies. It was listed on the HKEX main board in 2020 through the Chapter 18A listing regime. A team of lawyers based in the firm's Hong Kong office acted as Cayman Islands counsel to Genor Biopharma. The team was led by Partner, Juno Huang, with assistance from Legal Manager, Clare Tsang. Haiwen & Partners acted as Hong Kong and PRC legal counsel to Genor. Kirkland & Ellis acted as Hong Kong legal counsel to Edding Group and Jingtian & Gongcheng acted as PRC legal counsel to Edding Group. 迈普思为嘉和生物药业（开曼）控股有限公司（简称"嘉和生物药业"，一家根据《上市规则》第18A章在香港交易所上市的公司）与Edding Group Company Limited（简称"Edding Group"）的合并提供法律咨询服务。该交易于2025年12月30日完成后，嘉和生物药业已更名为"亿腾嘉和醫藥集團有限公司"，并继续在香港交易所上市。该交易估值约为8.74亿美元，标志着香港资本市场首宗涉及《上市规则》第18A章上市公司的反向收购。 面对来自美国及中国内地证券交易所日益激烈的竞争，香港交易所于2018年实施《上市规则》第18A章制度，旨在吸引高增长科技及生物科技领域尚未盈利的发行人。 嘉和生物药业是一家总部位于中国的创新驱动型生物制药公司，专注于肿瘤及自身免疫治疗领域的发现、研发与商业化。该公司于2020年通过《上市规则》第18A章上市制度在香港交易所主板上市。 迈普达律师事务所香港分所的律师团队担任嘉和生物药业的开曼群岛法律顾问。该团队由合伙人Juno Huang黄子容带领，并由法务经理Clare Tsang曾卓颖协助。 海问律师事务所担任嘉和生物药业的香港及中国内地法律顾问。凯易律师事务所担任Edding Group的香港法律顾问。竞天公诚律师事务所担任Edding Group的中国内地法律顾问。 Jingdong Industrials – HK IPO – closed on 11 December 2025 京东工业股份有限公司 –于香港的首次公开招股项目 – 于2025年12月11日完成 Press release: Maples Group Advises Jingdong Industrials' HK$2.978 Billion Hong Kong IPO - Maples Group Maples advised Jingdong Industrials Inc ("Jingdong Industrials") on its recent global offering of 211,200,000 shares and listing on the Main Board of the Hong Kong Stock Exchange ("HKEX"). The offering, which closed on 11 December 2025, raised gross proceeds of approximately HK$2.978 billion. Jingdong Industrials is the leading industrial supply chain technology and service provider in China. It is a subsidiary of JD.com, China's largest retailer by revenue, which has been listed on NASDAQ since 2014, and on the HKEX since 2020. A team of lawyers based in the firm's Hong Kong office acted as Cayman Islands counsel to Jingdong Industrials. The team was led by Partner and Head of Asia Corporate, Matt Roberts, Partner, Vivian Lee with assistance from Legal Manager, Charmaine Chow. The Group's Fund Services business acted as the Cayman Islands Share Registrar, with a team comprising Eastern Fong, Regional Head of Fund Services Asia, and Senior Vice President, Christy Poon. Skadden, Arps, Slate, Meagher & Flom acted as Hong Kong and US legal adviser while Shihui Partners acted as PRC legal adviser to Jingdong Industrials. Cleary Gottlieb Steen & Hamilton acted as Hong Kong and US legal adviser, and Han Kun Law Offices acted as the PRC legal adviser to the joint sponsors and the underwriters. 迈普思为京东工业股份有限公司（简称"京东工业"）近期全球发售211,200,000 股股份并在香港交易所主板上市提供了法律咨询服务。该项目已于2025 年12 月11 日完成，募集资金总额约29.78 亿港元。 京东工业是中国领先的工业供应链技术与服务提供商，是JD.com（简称"京东"）的子公司。按业务收入计，京东是中国最大规模的零售商，自2014 年起在纳斯达克上市，并自2020 年起在香港交易所上市。 迈普达律师事务所香港分所的律师团队担任京东工业的开曼群岛法律顾问。该团队由合伙人兼亚洲区企业事务团队主管Matt Roberts 马伯茨带领，合伙人Vivian Lee 李海宁，并由法务经理Charmaine Chow 周恩咏协助。迈普思集团的基金服务业务担任开曼群岛股份登记处，其团队成员包括基金服务亚洲区域总监Eastern Fong 方东及高级副总裁 Christy Poon 潘淑雯。 世达国际律师事务所担任京东工业的香港及美国法律顾问。世辉律师事务所担任京东工业的中国内地法律顾问。佳利（香港）律师事务所担任联席保荐人及承销商的香港及美国法律顾问。汉坤律师事务所担任联席保荐人及承销商的中国内地法律顾问。 TAIWAN STOCK EXCHANGE Elixiron Immunotherapeutics (Cayman) Limited - TW IPO – closed on 13 January 2026 Elixiron Immunotherapeutics (Cayman) Limited - 于台湾的首次公开募股项目 – 于2026年1月13日完成 Maples acted as Cayman Islands counsel to Elixiron Immunotherapeutics (Cayman) Limited ("Elixiron") in relation to its initial public listing on the Taipei Exchange Emerging Stock Board. Elixiron is a clinical-stage biotechnology company dedicated to developing precision immunotherapies for immune-mediated and neuroinflammatory diseases. The common stock of Elixiron commenced trading on the Emerging Stock Board on 13 January 2026. The Maples team comprised partner Juno Huang and associate Sarena Gong. Chien Yeh Law Offices acted as Taiwan counsel to Elixiron. 迈普思为 Elixiron Immunotherapeutics (Cayman) Limited（简称"安立玺荣"）就其在台湾证券交易所兴柜股票市场的首次公开发行提供开曼群岛法律服务。安立玺荣是一家临床阶段生物科技公司，专注于开发针对免疫介导疾病和神经炎症疾病的精准免疫疗法。安立玺荣的普通股已于 2026 年 1 月 13 日在兴柜板股票市场开始交易。迈普思负责此次项目的团队由合伙人Juno Huang黄子容带领，并由律师 Sarena Gong 龚天越协助。建业法律事务所担任安立玺荣的台湾法律顾问。 NASDAQ STOCK EXCHANGE M EVO GLOBAL ACQUISITION CORP II – SPAC listing – closed on 30 January 2026 M EVO GLOBAL ACQUISITION CORP II – 特殊目的收购公司上市项目– 于2026年1月30日完成 Maples acted as Cayman Islands counsel to M EVO GLOBAL ACQUISITION CORP II (the "Issuer") in relation to its initial public offering of 30,000,000 units on the Nasdaq Global Market. The Issuer is a special purpose acquisition company (SPAC) formed for the purpose of pursuing business combination targets. Whilst the Issuer may pursue an initial business combination in any industry, the Issuer intends to concentrate its search on businesses with a focus on those that own, operate, or are developing assets in the critical minerals sector that are fundamental to the economic and national security interests of the United States. The offering, which closed on 30 January 2026, raised approximately US$300 million. The team was led by Partner and Head of Asia Corporate, Matt Roberts, with assistance from Corporate legal managers, Kelvan Cheung and Jenny But. Loeb & Loeb LLP acted as US counsel to the Issuer and Greenberg Traurig, LLP acted as US counsel to the underwriters. 迈普思为M EVO GLOBAL ACQUISITION CORP II（简称"发行人"）就其首次公开招股发行30,000,000个单位及于纳斯达克全球市场上市项目担任开曼群岛法律顾问。发行人是一家专注于业务合并的特殊目的收购公司。尽管发行人可能在任何行业寻求首次业务合并，但发行人拟将重点搜寻方向集中在与美国经济和国家安全利益密切相关的关键矿产领域中拥有、运营或正在开发资产的企业。该项目已于2026年1月30日完成，募资约3亿美元。迈普思负责此次项目的团队由合伙人兼亚洲区企业事务团队主管Matt Roberts 马伯茨带领，并由法务经理Kelvan Cheung张逸聪及Jenny But毕绮雯协助。乐博律师事务所担任发行人的美国法律顾问。Greenberg Traurig, LLP担任包销商的美国法律顾问。 |
|
SPAC Business Combinations 特殊目的收购公司的业务合并 |
TechStar Acquisition Corporation. – De-SPAC - closed on 10 December 2025 TechStar Acquisition Corporation. – De-SPAC – 于2025年12月10日完成 Press release: Maples Group Advises on Largest Hong Kong de-SPAC Transaction - Maples Group Maples advised TechStar Acquisition Corporation ("TechStar"), a Cayman Islands special purpose acquisition company ("SPAC") listed on The Stock Exchange of Hong Kong Limited (the "HKEx"), and Seyond Holdings Ltd. ("Seyond") on their de-SPAC transaction, which completed on 10 December 2025. This is the third Hong Kong de-SPAC since the launch of the SPAC listing regime in Hong Kong in 2022 and marks the largest Hong Kong de-SPAC transaction to date, with an equity value of HK$11.7 billion. Established in 2016, Seyond is a global leader in highfidelity LiDAR (Light Detection and Ranging) solutions, powering a safer, smarter and more mobile world across the automotive, intelligent transportation, robotics and infrastructure industries. It is the first company to achieve mass production of automotive-grade high-performance LiDAR. Seyond ranked first globally in sales revenue of passenger car LiDAR solutions in 2022 and 2023 . A team of lawyers based in the firm's Hong Kong office acted as Cayman Islands counsel to TechStar. The team was led by Partner and Head of Asia Corporate, Matt Roberts, with assistance from Legal Manager, Charmaine Chow. The Maples Group's Fund Services team also supported this transaction, led by Eastern Fong, Regional Head of Fund Services – Asia and Senior Vice President, Christy Poon. Baker & McKenzie and Han Kun Law Offices LLP acted as Hong Kong and US counsel to TechStar. Davis Polk & Wardwell acted as Hong Kong and US counsel, while Fangda Partners acted as PRC counsel to Seyond. Allen Overy Shearman Sterling LLP acted as Hong Kong counsel to the joint sponsors, while Jingtian & Gongcheng acted as PRC counsel to the joint sponsors. 迈普思为TechStar Acquisition Corporation（简称"TechStar"，一家于香港联合交易所有限公司（简称"香港交易所"）上市的开曼群岛特殊目的收购公司（简称"SPAC"））及Seyond Holdings Ltd.（简称"图达通"）就其de-SPAC交易提供法律咨询服务。该交易已于2025年12月10日完成。这是自2022年香港推行SPAC上市制度以来第三宗香港de-SPAC交易，并以117亿港元的股权价值成为香港迄今规模最大的de-SPAC交易。 图达通成立于2016年，是高性能激光雷达（光探测与测距）解决方案领域的全球领导者，赋能汽车、智慧交通、机器人及基础设施行业以构建更安全、更智能及更便捷的世界。图达通是首家实现车规级高性能激光雷达量产的公司，其乘用车激光雷达解决方案于2022年及2023年的销售收入均位居全球首位。 迈普达律师事务所香港分所的律师团队担任TechStar的开曼群岛法律顾问。该团队由合伙人兼亚洲区企业事务团队主管Matt Roberts马伯茨带领，并由法务经理Charmaine Chow周恩咏协助。迈普思集团的基金服务团队也为该交易提供专业服务，该团队由基金服务亚洲区域总监Eastern Fong 方东及高级副总裁 Christy Poon 潘淑雯带领。 贝克‧麦坚时律师事务所及汉坤律师事务所担任TechStar的香港及美国法律顾问。达维律师事务所（Davis Polk & Wardwell）担任图达通的香港及美国法律顾问。方达律师事务所担任图达通的中国内地法律顾问。安理谢尔曼思特灵律师事务所担任联席保荐人的香港法律顾问。竞天公诚律师事务所担任联席保荐人的中国内地法律顾问。 |
|
Debt Securities 債務證券 |
Hansoh Pharmaceutical Group Company Limited – bond issuance - closed on 4 February 2026 翰森製藥集團有限公司 ─ 发行债券 ──于2026年2月4日完成 Acted as the Cayman Islands legal counsel to Hansoh Pharmaceutical Group Company Limited (the "Issuer") on its issuance of HK$4,680 million zero coupon convertible bonds due 2033 (the "Bonds") and the listing of the Bonds on the Vienna MTF operated by the Vienna Stock Exchange. The issuance completed on 3 February 2026, followed by the listing on 4 February 2026. Hansoh Pharmaceutical Group Company Limited is a leading pharmaceutical company engaged in the research, development and production and sale of a broad portfolio of pharmaceutical products. The Maples team was led by Matt Roberts, Partner and Head of Corporate, Asia, with support from Legal Managers Kelvan Cheung and Clare Tsang. Cleary Gottlieb Steen & Hamilton (Hong Kong) acted as English and Hong Kong legal counsel to the Issuer; whilst Linklaters acted as English and Hong Kong legal counsels to the managers, Citigroup Global Markets Limited and Morgan Stanley Asia Limited. 担任翰森製藥集團有限公司（简称" 该发行人"）的开曼群岛法律顾问，协助其发行本金总额为46.8亿港元于2033年到期的零息可转换债券（简称" 该等债券"）并协助该等债券在维也纳证券交易所运营的Vienna MTF上市。该等债券的发行已于2026年2月3日完成，并于2026年2月4日上市。 翰森製藥集團有限公司是一家领先的制药公司，专门从事一系列药品的研发、生产及销售。 迈普思负责此次项目的团队由合伙人兼亚洲区企业事务团队主管 Matt Roberts马伯茨带领，并由法务经理Kelvan Cheung张逸聪及Clare Tsang曾卓颖提供协助。佳利（香港）律师事务所担任该发行人的英国及中国香港法律顾问。年利达律师事务所担任经办人花旗环球金融有限公司（Citigroup Global Markets Limited）和摩根士丹利亚洲有限公司（Morgan Stanley Asia Limited）的英国及中国香港法律顾问。 Sun Hung Kai & Co. (BVI) Limited – notes offering - closed on 22 January 2026 Sun Hung Kai & Co. (BVI) Limited– 发行票据– 于2026年1月22日完成 Maples cted as BVI legal counsel to Sun Hung Kai & Co. (BVI) Limited in connection with (i) tender offer of its outstanding US$450,000,000 5.00 per cent. guaranteed notes due 2026 (comprising the U.S.$75,000,000 5.00 per cent. guaranteed notes due 2026 issued on 2 March 2022 consolidated and forming a single series with the U.S.$375,000,000 5.00 per cent. guaranteed notes due 2026 issued on 7 September 2021), and (ii) issue of US$250,000,000 6.75 per cent guaranteed notes due 2029 under its US$3,000,000,000 medium term note programme guaranteed by Sun Hung Kai & Co. Limited. Maples team is led by Lorraine Pao with assistance from legal manager Haldane Leung. Clifford Chance acted as the Issuer's international counsel and Linklaters acted as dealers' international counsel. 迈普思担任 Sun Hung Kai & Co. (BVI) Limited（简称"该发行人"）的英属维尔京群岛法律顾问，协助其完成 (i)于2026年到期未偿还本金总额为4.5亿美元的5%有担保票据（包括 2022 年 3 月 2 日发行本金总额为 7,500 万美元、票面利率 5.00%、2026 年到期的有担保票据，与 2021 年 9 月 7 日发行本金总额为 3.75 亿美元、票面利率 5.00%、2026 年到期的有担保票据合并为单一系列）的收购要约；及 (ii) 在其由新鸿基有限公司担保的本金总额为30亿美元中期票据计划下发行于2029年到期本金总额为2.5亿美元的6.75%有担保票据。迈普思负责此次项目的团队由合伙人Lorraine Pao鲍咏璁带领，并由法务经理Haldane Leung梁恺庭提供协助。高伟绅律师行担任该发行人的国际法律顾问，年利达律师事务所担任交易商的国际法律顾问。 |
|
Business Combination 业务合并项目 |
MICROPORT CARDIAC RHYTHM MANAGEMENT LIMITED – Cayman merger - completed on 19 December 2025 微创心律管理有限公司 – 开曼群岛法定合并–于2025年12月19日完成 Maples acted as Cayman legal counsel to MICROPORT CARDIAC RHYTHM MANAGEMENT LIMITED on its statutory merger with MicroPort CardioFlow CRM Limited (the "CRM"), an indirectly wholly owned subsidiary of MicroPort CardioFlow Medtech Corporation (the "Listco") pursuant to Part 16 of the Cayman Companies Act (As Revised) (the "Merger"). As consideration of the Merger, the Listco will allot and issue new shares to the existing shareholders of CRM prior to the Merger and immediately after the Merger, CRM as surviving company along with its subsidiaries will become indirect subsidiaries of the Listco. The Maples team is led by partner Lorraine Pao with assistance from legal manager Haldane Leung. Sidley Austin acted as Hong Kong legal counsel to CRM. 迈普思担任微创心律管理有限公司的开曼群岛法律顾问，就其依据经修订的《开曼群岛公司法》（Cayman Companies Act (As Revised)）第16部与微创心通医疗科技有限公司（简称"该上市公司"）的间接全资子公司 MicroPort CardioFlow CRM Limited（简称"CRM"）的法定合并（简称"合并"）提供法律咨询服务。作为本次合并的对价，该上市公司将在合并前向 CRM 的现有股东配发及发行新股；在合并完成后，作为存续公司的 CRM 及其子公司将立即成为该上市公司的间接子公司。迈普思负责此次项目的团队由合伙人Lorraine Pao鲍咏璁带领，并由法务经理Haldane Leung梁恺庭协助。盛德律师事务所担任CRM的香港法律顾问。 |
|
Restructuring 债务重组项目 |
Maples Group Advises on Trio of Offshore Debt Restructurings Press release: Maples Group Advises on Trio of Offshore Debt Restructurings - Maples Group Maples Global Dispute Resolution & Insolvency and Finance teams advised on the completion of three significant offshore debt restructurings in December 2025. These successful mandates demonstrate the depth and strength of the firm's multi-jurisdictional and multi-disciplinary capabilities and its capacity to act on the most significant matters in the market. Details on the recent debt restructuring mandates are outlined below:
The team advised Country Garden on the successful restructuring of approximately US$17.7billion of its offshore debt, one of the largest and most complex offshore restructurings by a Chinese issuer, in terms of both debt quantum and the number and diversity of creditors.
The team advised CIFI on the successful restructuring of approximately US$8.1billion of its offshore debt.
The team advised Sunac on the successful restructuring of approximately US$9.6 billion of its offshore debt. This follows the firm acting for Sunac on its US$10.2 billion offshore debt restructuring in 2023.1 A multi-jurisdictional team of lawyers based in the Maples Group's Hong Kong, Cayman Islands and British Virgin Islands ("BVI") offices acted as Cayman Islands and BVI counsel to these companies. Led by Hong Kong Partners, Nick Stern and Lorraine Pao, the team also included Cayman Islands Partners, Nick Herrod and Christian La Roda Thomas, BVI Partner, Matthew Freeman and Hong Kong Of Counsel, Jean Bao. 迈普思环球争议解决及破产事务团队及融资事务团队为三项重大境外债务重组提供法律咨询服务。这些项目已于2025年12月完成。这些成功案例充份彰显了本所在跨司法管辖区、跨专业领域方面的深厚实力，以及处理市场重大项目的卓越能力。 已于近期完成的债务重组项目概述如下：
该团队为碧桂园约177亿美元的境外债务重组提供法律咨询服务。该重组无论从债务规模及债权人数量及种类而言，均属规模最大、最为复杂的中国发行人所进行的境外债务重组之一。
该团队为旭辉约81亿美元的境外债务重组提供法律咨询服务。
该团队为融创约96亿美元的境外债务重组提供法律咨询服务。此前，本所曾于2023年协助融创完成其102亿美元的境外债务重组 。 迈普思集团香港分所、开曼群岛分所及英属维尔京群岛（简称"BVI"）分所的跨地区律师团队担任上述公司的开曼群岛及BVI法律顾问。该团队由香港分所合伙人Nick Stern施礼康及Lorraine Pao鲍咏璁带领，团队成员亦包括开曼群岛分所合伙人Nick Herrod及Christian La Roda Thomas、BVI 分所合伙人Matthew Freeman，以及香港分所顾问律师Jean Bao鲍沣粲。 |
|
Funds and Investment Management 基金及投资管理项目 |
Maples Group Advises Nomura on Launch of Nomura Fund Select – Apollo Multi Alternative Strategies Fund Launch Press release: Maples Group Advises Nomura on Launch of Nomura Fund Select – Apollo Multi Alternative Strategies Fund Launch - Maples Group Maples Asia Funds & Investment Management practice has advised Global Funds Trust Company ("GFTC"), a member of the Nomura Group, on the launch of Nomura Fund Select – Apollo Multi Alternative Strategies Fund (the "Fund"). The Fund, which launched on 22 December 2025, is structured as a Cayman Islands unit trust and is authorised for public offering in Japan. The Fund will be distributed in Japan by Nomura Securities Co., Ltd. and the Fund's investment adviser is Nomura Asset Management Co., Ltd. The Fund's investment objective is to provide returns from capital invested in private equity, private credit, infrastructure, real estate and/or other investments, while reducing investment risks through diversification across countries, sectors and investment styles. The Fund will seek to achieve its investment objective by investing substantially all of its assets in Apollo Aligned Alternatives (E-1), an open-ended investment compartment of Apollo Private Markets SICAV. A team of lawyers based in the firm's Singapore office acted as Cayman Islands counsel to GFTC and was led by Funds & Investment Management Partner, Nick Harrold and assisted by Associates Costa Valtas and Nicholas Lim. Maples Group Advises Glenwood on US$1.1 Billion South Korea-Focused Fund Press release: Maples Group Advises Glenwood on US$1.1 Billion South Korea-Focused Fund - Maples Group Maples advised Glenwood Private Equity ("Glenwood") on the formation of Glenwood Private Equity Fund III, with total commitments of approximately US$1.1 billion. Glenwood is a leading independent investment firm headquartered in Seoul that primarily focuses on buyout opportunities in Korea with cumulative assets under management of US$3.9 billion. A team of lawyers based in the firm's Hong Kong office acted as Cayman Islands legal counsel to Glenwood and was led by Partner in the Funds & Investment Management team, Sharon Yap, and Of Counsel, Dan Won. The Maples Group's Fiduciary Services team was led by Global Head of Fiduciary, Charlie Sparrow, who supported the launch of the Fund. Maples Group Advises ORIX on US$2.5 Billion Japan-Targeted Private Equity Fund Press release: Maples Group Advises ORIX on US$2.5 Billion Japan-Targeted Private Equity Fund - Maples Group Maples advised and supported ORIX Corporation ("ORIX") on the launch of a US$2.5 billion Japan-targeted private equity fund (the "Fund"), in partnership with Qatar Investment Authority. This is the first time that ORIX has launched a fund that welcomes capital from an international third-party investor for domestic private equity investment in Japan. The Fund will invest in Japanese companies with an enterprise value of at least 30 billion yen (approx. 200 million USD) per investment. A team of lawyers based in the firm's Hong Kong office acted as Cayman Islands counsel and was led by Funds & Investment Management Partner, Sharon Yap and Aidan O'Regan. The Maples Group's Fund Services team and Fiduciary Services team led by Eastern Fong, Regional Head of Fund Services – Asia, and Charlie Sparrow, Regional Head of Fiduciary – Asia respectively, provided fund administration services and governance solutions and were heavily involved in the launch of the Fund. |
PRESS RELEASE
10 February 2026
Maples Group Deals Announcement | Asia | Dec 25 To Feb 26
Maples Group
Contributor
The Maples Group is a leading service provider offering clients a comprehensive range of legal services on the laws of the British Virgin Islands, the Cayman Islands, Ireland, Jersey and Luxembourg, and is an independent provider of fiduciary, fund services, regulatory and compliance, and entity formation and management services.
Maples advised MiniMax Group Inc. (“MiniMax”) in
relation to its initial public offering (“IPO”) on the
Main Board of the Hong Kong Stock Exchange